Alejandro Horga

Summary

Country: Spain

Publications

  1. doi request reprint FTY720 (fingolimod) for relapsing multiple sclerosis
    Alejandro Horga
    Clinical Neuroinmunology Unit, Multiple Sclerosis Center of Catalonia CEM Cat, Vall d Hebron University Hospital, Barcelona, Spain
    Expert Rev Neurother 8:699-714. 2008
  2. doi request reprint Fingolimod for relapsing multiple sclerosis: an update
    Alejandro Horga
    Multiple Sclerosis Centre of Catalonia CEM Cat, Vall d Hebron University Hospital, Passeig Vall d Hebron, 119 129, 08035 Barcelona, Spain
    Expert Opin Pharmacother 11:1183-96. 2010

Collaborators

Detail Information

Publications2

  1. doi request reprint FTY720 (fingolimod) for relapsing multiple sclerosis
    Alejandro Horga
    Clinical Neuroinmunology Unit, Multiple Sclerosis Center of Catalonia CEM Cat, Vall d Hebron University Hospital, Barcelona, Spain
    Expert Rev Neurother 8:699-714. 2008
    ..These results are awaiting confirmation in the three ongoing Phase III clinical trials evaluating FTY720 for relapsing-remitting multiple sclerosis...
  2. doi request reprint Fingolimod for relapsing multiple sclerosis: an update
    Alejandro Horga
    Multiple Sclerosis Centre of Catalonia CEM Cat, Vall d Hebron University Hospital, Passeig Vall d Hebron, 119 129, 08035 Barcelona, Spain
    Expert Opin Pharmacother 11:1183-96. 2010
    ..Fingolimod is an oral sphingosine-1-phosphase (S1P) receptor modulator under clinical investigation for the treatment of relapsing-remitting and primary progressive MS...